Cargando…
HNPCC: Six new pathogenic mutations
BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disease with a high risk for colorectal and endometrial cancer caused by germline mutations in DNA mismatch-repair genes (MMR). HNPCC accounts for approximately 2 to 5% of all colorectal cancers. Here we present...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC446196/ https://www.ncbi.nlm.nih.gov/pubmed/15217520 http://dx.doi.org/10.1186/1471-2350-5-16 |
_version_ | 1782121560766676992 |
---|---|
author | Kunstmann, Erdmute Vieland, Judith Brasch, Frank E Hahn, Stephan A Epplen, Joerg T Schulmann, Karsten Schmiegel, Wolff |
author_facet | Kunstmann, Erdmute Vieland, Judith Brasch, Frank E Hahn, Stephan A Epplen, Joerg T Schulmann, Karsten Schmiegel, Wolff |
author_sort | Kunstmann, Erdmute |
collection | PubMed |
description | BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disease with a high risk for colorectal and endometrial cancer caused by germline mutations in DNA mismatch-repair genes (MMR). HNPCC accounts for approximately 2 to 5% of all colorectal cancers. Here we present 6 novel mutations in the DNA mismatch-repair genes MLH1, MSH2 and MSH6. METHODS: Patients with clinical diagnosis of HNPCC were counselled. Tumor specimen were analysed for microsatellite instability and immunohistochemistry for MLH1, MSH2 and MSH6 protein was performed. If one of these proteins was not detectable in the tumor mutation analysis of the corresponding gene was carried out. RESULTS: We identified 6 frameshift mutations (2 in MLH1, 3 in MSH2, 1 in MSH6) resulting in a premature stop: two mutations in MLH1 (c.2198_2199insAACA [p.N733fsX745], c.2076_2077delTG [p.G693fsX702]), three mutations in MSH2 (c.810_811delGT [p.C271fsX282], c.763_766delAGTGinsTT [p.F255fsX282], c.873_876delGACT [p.L292fsX298]) and one mutation in MSH6 (c.1421_1422dupTG [p.C475fsX480]). All six tumors tested for microsatellite instability showed high levels of microsatellite instability (MSI-H). CONCLUSIONS: HNPCC in families with MSH6 germline mutations may show an age of onset that is comparable to this of patients with MLH1 and MSH2 mutations. |
format | Text |
id | pubmed-446196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-4461962004-07-09 HNPCC: Six new pathogenic mutations Kunstmann, Erdmute Vieland, Judith Brasch, Frank E Hahn, Stephan A Epplen, Joerg T Schulmann, Karsten Schmiegel, Wolff BMC Med Genet Research Article BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disease with a high risk for colorectal and endometrial cancer caused by germline mutations in DNA mismatch-repair genes (MMR). HNPCC accounts for approximately 2 to 5% of all colorectal cancers. Here we present 6 novel mutations in the DNA mismatch-repair genes MLH1, MSH2 and MSH6. METHODS: Patients with clinical diagnosis of HNPCC were counselled. Tumor specimen were analysed for microsatellite instability and immunohistochemistry for MLH1, MSH2 and MSH6 protein was performed. If one of these proteins was not detectable in the tumor mutation analysis of the corresponding gene was carried out. RESULTS: We identified 6 frameshift mutations (2 in MLH1, 3 in MSH2, 1 in MSH6) resulting in a premature stop: two mutations in MLH1 (c.2198_2199insAACA [p.N733fsX745], c.2076_2077delTG [p.G693fsX702]), three mutations in MSH2 (c.810_811delGT [p.C271fsX282], c.763_766delAGTGinsTT [p.F255fsX282], c.873_876delGACT [p.L292fsX298]) and one mutation in MSH6 (c.1421_1422dupTG [p.C475fsX480]). All six tumors tested for microsatellite instability showed high levels of microsatellite instability (MSI-H). CONCLUSIONS: HNPCC in families with MSH6 germline mutations may show an age of onset that is comparable to this of patients with MLH1 and MSH2 mutations. BioMed Central 2004-06-24 /pmc/articles/PMC446196/ /pubmed/15217520 http://dx.doi.org/10.1186/1471-2350-5-16 Text en Copyright © 2004 Kunstmann et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Research Article Kunstmann, Erdmute Vieland, Judith Brasch, Frank E Hahn, Stephan A Epplen, Joerg T Schulmann, Karsten Schmiegel, Wolff HNPCC: Six new pathogenic mutations |
title | HNPCC: Six new pathogenic mutations |
title_full | HNPCC: Six new pathogenic mutations |
title_fullStr | HNPCC: Six new pathogenic mutations |
title_full_unstemmed | HNPCC: Six new pathogenic mutations |
title_short | HNPCC: Six new pathogenic mutations |
title_sort | hnpcc: six new pathogenic mutations |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC446196/ https://www.ncbi.nlm.nih.gov/pubmed/15217520 http://dx.doi.org/10.1186/1471-2350-5-16 |
work_keys_str_mv | AT kunstmannerdmute hnpccsixnewpathogenicmutations AT vielandjudith hnpccsixnewpathogenicmutations AT braschfranke hnpccsixnewpathogenicmutations AT hahnstephana hnpccsixnewpathogenicmutations AT epplenjoergt hnpccsixnewpathogenicmutations AT schulmannkarsten hnpccsixnewpathogenicmutations AT schmiegelwolff hnpccsixnewpathogenicmutations |